Skip to content
compulsory patent licensing india

BioSpectrum Asia – Compulsory License of Bayer’s Nexavar

BioSpectrum Asia – Debate over compulsory licensing of Bayer’s Nexavar  Originally published here. Full Article: India allows compulsory licensing of Bayer’s Nexavar In March 2012, the Indian Patent office granted first compulsory license to NATCO… 

pharma patent attorney

Swissinfo – Novartis Patent Case – Indacaterol – Onbrez Delhi High Court Judgement

Swissinfo is Swiss Government’s International Publication Service managed by Swiss Broadcasting Corporation (SBC). Originally published here. Views on Delhi High Court’s ruling in Novartis patent dispute: “The ruling is totally in line with existing laws,…